Drug Profile
Research programme: HIV DNA vaccine - Cellectis/Karolinska Institute/SMI
Alternative Names: HIVIS-07Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cyto Pulse Sciences; Karolinska Institute; Swedish Institute for Infectious Disease Control
- Developer Cellectis; Karolinska Institute
- Class AIDS vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-1-infections(Prevention) in Sweden (Intradermal)
- 23 Feb 2010 Preclinical trials in HIV-1 infections prevention in Sweden (Intradermal)